SCHEMBL9945683

SCHEMBL9945683

CC(C)CCCN(CCO)CCO

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
LMNA P02545 2/20 0.36
MAPT P10636 1/20 0.33
SLC29A1 Q99808 1/20 0.33
KDM4C Q9H3R0 2/20 0.32
KDM4A O75164 1/20 0.32
PHF8 Q9UPP1 1/20 0.32
KDM2A Q9Y2K7 1/20 0.32
TSHR P16473 1/20 0.32
GBA1 P04062 1/20 0.32
PTPN1 P18031 1/20 0.31
BLM P54132 1/20 0.31
OPRM1 P35372 2/20 0.31
OPRD1 P41143 2/20 0.31
OPRK1 P41145 2/20 0.31
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
HPGD P15428 1/20 0.30
MAPK1 P28482 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9945711 0.91 ALDH1A1 (0.33) ALDH1A1LMNATSHRCYP1A2CYP2C9
SCHEMBL2047008 0.91 LMNA (0.39) ALDH1A1LMNAMAPTSLC29A1KDM4C
SCHEMBL31365936 0.91 LMNA (0.39) ALDH1A1LMNAMAPTSLC29A1KDM4C
SCHEMBL9319584 0.91 LMNA (0.39) ALDH1A1LMNAMAPTSLC29A1KDM4C
SCHEMBL15563205 0.91 LMNA (0.39) ALDH1A1LMNAMAPTSLC29A1KDM4C
SCHEMBL31365935 0.91 LMNA (0.39) ALDH1A1LMNAMAPTSLC29A1KDM4C
SCHEMBL7759645 0.91 LMNA (0.39) ALDH1A1LMNAMAPTSLC29A1KDM4C
SCHEMBL5652783 0.91 LMNA (0.39) ALDH1A1LMNAMAPTSLC29A1KDM4C
SCHEMBL18292460 0.89 CYP1A2 (0.44) ALDH1A1LMNAOPRM1CYP1A2CYP2C9
SCHEMBL6239055 0.89 LMNA (0.37) ALDH1A1LMNASLC29A1KDM4CKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183168-A1 IONIZABLE LIPIDS AND COMPOSITIONS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-06-15 US disclosed
US-20220040331-A1 COMPOSITIONS AND METHODS FOR TRANSFECTING CELLS AMRYT RESEARCH LIMITED (IE) 2022-02-10 US disclosed
US-20200330396-A1 NONVIRAL GENE TRANSFER TO THE SUPRACHOROIDAL SPACE THE JOHNS HOPKINS UNIVERSITY 2020-10-22 US disclosed
US-20190194390-A1 AMINO-POLYESTERS FOR DRUG DELIVERY MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2019-06-27 US disclosed
WO-2019070727-A2 NONVIRAL GENE TRANSFER TO THE SUPRACHOROIDAL SPACE THE JOHNS HOPKINS UNIVERSITY (US) 2019-04-11 WO disclosed
US-9760030-B2 Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus CANON KABUSHIKI KAISHA (JP) 2017-09-12 US disclosed
US-9717694-B2 Peptide/particle delivery systems THE JOHNS HOPKINS UNIVERSITY (US) 2017-08-01 US disclosed
EP-2632965-B1 AQUEOUS CATIONIC POLYURETHANE DISPERSIONS LUBRIZOL ADVANCED MAT INC (US) 2017-04-26 EP disclosed
US-20160116853-A1 ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS CANON KABUSHIKI KAISHA (JP) 2016-04-28 US disclosed
US-8932370-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2015-01-13 US disclosed
US-8562966-B2 End-modified poly(beta-amino esters) and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-10-22 US disclosed
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2012-11-01 US disclosed
US-20120149630-A1 END-MODIFIED POLY(BETA-AMINO ESTERS) AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2012-06-14 US disclosed
US-20110178074-A1 ANTIPATHOGENIC BENZAMIDE COMPOUNDS GENESOFT PHARMACEUTICALS, INC. (US) 2011-07-21 US disclosed
US-20080242626-A1 End-Modified Poly(beta-amino esters) and Uses Thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2008-10-02 US disclosed
US-20080242626-A1 End-Modified Poly(beta-amino esters) and Uses Thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2008-10-02 US disclosed
US-20080145338-A1 Acrylate-terminated poly(beta-amino esters); high throughput assay; biocompatability NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-06-19 US disclosed
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS GENESOFT PHARMACEUTICALS, INC. (US) 2008-04-17 US disclosed
US-7265129-B2 Anti-infective biaryl compounds GENESOFT PHARMACEUTICALS, INC. (US) 2007-09-04 US disclosed
US-7265129-B2 Anti-infective biaryl compounds GENESOFT PHARMACEUTICALS, INC. (US) 2007-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080145338-A1 Acrylate-terminated poly(beta-amino esters); high throughput assay; biocompatability ACP1, ILK, BCAT2 ALDH1A1 891/4885LMNA 1926/4885MAPT 815/4885
US-20120149630-A1 END-MODIFIED POLY(BETA-AMINO ESTERS) AND USES THEREOF PARN, PARG, POLL ALDH1A1 2664/4885LMNA 566/4885MAPT 1942/4885
US-20080242626-A1 End-Modified Poly(beta-amino esters) and Uses Thereof PARN, PARG, POLL ALDH1A1 2664/4885LMNA 566/4885MAPT 1942/4885
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 ALDH1A1 192/4885LMNA 316/4885MAPT 2715/4885
US-20230183168-A1 IONIZABLE LIPIDS AND COMPOSITIONS AND USES THEREOF SLC10A1, PYGL, FABP1 ALDH1A1 3336/4885LMNA 483/4885MAPT 23/4885
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS QTRT1, Q6ZSR9, QTRT2 ALDH1A1 2229/4885LMNA 3249/4885MAPT 4305/4885
US-20200330396-A1 NONVIRAL GENE TRANSFER TO THE SUPRACHOROIDAL SPACE MYOC, MTREX, SLC26A4 ALDH1A1 2505/4885LMNA 402/4885MAPT 3174/4885
US-20110178074-A1 ANTIPATHOGENIC BENZAMIDE COMPOUNDS CASP3, BCL3, ME3 ALDH1A1 1365/4885LMNA 954/4885MAPT 4787/4885
US-20190194390-A1 AMINO-POLYESTERS FOR DRUG DELIVERY DNPEP, NPEPPS, ANPEP ALDH1A1 1113/4885LMNA 2232/4885MAPT 1715/4885
US-20220040331-A1 COMPOSITIONS AND METHODS FOR TRANSFECTING CELLS TK1, XPA, RNASE1 ALDH1A1 3345/4885LMNA 200/4885MAPT 3525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.